group_id,Component_37,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00531,0.6793368936304943,FUN_001545-T1,Peve_00033291,Pocillopora_meandrina_HIv1___RNAseq.g15386.t1,three_way,49.809666666666665,,,,,,,,,,,,,,,,,
OG_07144,0.5646186202985555,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_06154,0.5188465016986253,FUN_027987-T1,Peve_00023127,Pocillopora_meandrina_HIv1___RNAseq.g14022.t1,three_way,64.95433333333334,,,,,,,,,,,,,,,,,
OG_09826,0.5053314265704267,FUN_042659-T1,Peve_00031591,Pocillopora_meandrina_HIv1___RNAseq.g4898.t1,three_way,46.13633333333333,,,,,,,,,,,,,,,,,
OG_09075,0.5018421058493643,FUN_038804-T1,Peve_00007218,Pocillopora_meandrina_HIv1___RNAseq.g28539.t1c,three_way,93.94983333333332,FUN_038804-T1,Q90YS3,,,,,88.7,231.0,2.5e-113,409.8,sp|Q90YS3|RS2_ICTPU Small ribosomal subunit protein uS5 OS=Ictalurus punctatus OX=7998 GN=rps2 PE=2 SV=1,,,,,,
OG_05071,0.4772730262436315,FUN_023293-T1,Peve_00003652,Pocillopora_meandrina_HIv1___RNAseq.g23035.t1,three_way,68.382,,,,,,,,,,,,,,,,,
OG_09295,0.4726267730529816,FUN_040146-T1,Peve_00038108,Pocillopora_meandrina_HIv1___RNAseq.g8511.t1,three_way,40.80866666666667,,,,,,,,,,,,,,,,,
OG_02408,0.4512576316697482,FUN_009228-T2,Peve_00014803,Pocillopora_meandrina_HIv1___RNAseq.g6343.t1,three_way,63.64683333333333,FUN_009228-T2,Q24JV9,,,,,50.0,106.0,4.5000000000000003e-23,113.6,sp|Q24JV9|L3BPA_DANRE Galectin-3-binding protein A OS=Danio rerio OX=7955 GN=lgals3bpa PE=2 SV=1,,,,,,
OG_00314,0.4361732885690917,FUN_001118-T1,Peve_00029370,Pocillopora_meandrina_HIv1___RNAseq.g22341.t1,three_way,65.59533333333333,FUN_001118-T1,P00918,CAH2_HUMAN,,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II) (Cyanamide hydratase CA2) (EC 4.2.1.69),Homo sapiens (Human),48.1,262.0,3.7e-63,243.0,sp|P00918|CAH2_HUMAN Carbonic anhydrase 2 OS=Homo sapiens OX=9606 GN=CA2 PE=1 SV=2,GO:0002009; GO:0004064; GO:0004089; GO:0005737; GO:0005829; GO:0005886; GO:0008270; GO:0015670; GO:0018820; GO:0032230; GO:0032849; GO:0038166; GO:0043209; GO:0044070; GO:0045177; GO:0046903; GO:0051453; GO:0070050; GO:0070062; GO:2001150; GO:2001225,"angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; morphogenesis of an epithelium [GO:0002009]; neuron cellular homeostasis [GO:0070050]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of monoatomic anion transport [GO:0044070]; secretion [GO:0046903]",apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886],arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; cyanamide hydratase activity [GO:0018820]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0005886; GO:0016787; GO:0016829; GO:0043226,catalytic activity; cytosol; plasma membrane; hydrolase activity; lyase activity; organelle
OG_06174,0.42601024771296,FUN_028030-T1,Peve_00044201,Pocillopora_meandrina_HIv1___RNAseq.g13933.t1,three_way,44.60566666666666,,,,,,,,,,,,,,,,,
OG_00948,0.4221355998426648,FUN_004307-T1,Peve_00033930,Pocillopora_meandrina_HIv1___RNAseq.g11779.t1,three_way,63.568666666666665,FUN_004307-T1,O96952,,,,,51.0,102.0,1.3e-23,111.3,sp|O96952|THIO_GEOCY Thioredoxin OS=Geodia cydonium OX=6047 GN=THIO PE=3 SV=1,,,,,,
OG_06218,0.4197945692857102,FUN_028160-T1,Peve_00000617,Pocillopora_meandrina_HIv1___RNAseq.g29828.t1,three_way,77.55183333333333,,,,,,,,,,,,,,,,,
OG_07455,0.4046637838453325,FUN_033951-T1,Peve_00032117,Pocillopora_meandrina_HIv1___RNAseq.g28360.t1,three_way,65.717,,,,,,,,,,,,,,,,,
OG_02728,0.4043718859372617,FUN_011252-T1,Peve_00024318,Pocillopora_meandrina_HIv1___RNAseq.g11307.t1,three_way,52.192,,,,,,,,,,,,,,,,,
OG_01098,0.389728519080912,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_07251,0.3782257099833068,FUN_032993-T1,Peve_00014539,Pocillopora_meandrina_HIv1___RNAseq.g24472.t1,three_way,86.36833333333334,FUN_032993-T1,P47826,,,,,72.1,280.0,9.999999999999999e-116,417.9,sp|P47826|RLA0_CHICK Large ribosomal subunit protein uL10 OS=Gallus gallus OX=9031 GN=RPLP0 PE=1 SV=1,,,,,,
OG_02502,0.3720969640139214,FUN_009857-T2,Peve_00009100,Pocillopora_meandrina_HIv1___RNAseq.g24506.t1,three_way,84.31183333333333,FUN_009857-T2,Q92005,,,,,85.1,462.0,2.1999999999999998e-231,802.7,sp|Q92005|EF1A_DANRE Elongation factor 1-alpha OS=Danio rerio OX=7955 GN=eef1a PE=2 SV=1,,,,,,
OG_09247,0.369361372855862,FUN_040037-T1,Peve_00040431,Pocillopora_meandrina_HIv1___RNAseq.g8456.t1,three_way,47.013000000000005,FUN_040037-T1,P02788,TRFL_HUMAN,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],Homo sapiens (Human),26.8,567.0,3.6e-34,149.1,sp|P02788|TRFL_HUMAN Lactotransferrin OS=Homo sapiens OX=9606 GN=LTF PE=1 SV=6,GO:0001503; GO:0001530; GO:0001817; GO:0002227; GO:0003677; GO:0004252; GO:0004869; GO:0005506; GO:0005576; GO:0005615; GO:0005634; GO:0005737; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0006959; GO:0008201; GO:0009986; GO:0019731; GO:0019732; GO:0030141; GO:0031640; GO:0031665; GO:0032680; GO:0032780; GO:0032991; GO:0033690; GO:0034145; GO:0035580; GO:0042581; GO:0043066; GO:0043123; GO:0043539; GO:0044793; GO:0045071; GO:0045669; GO:0048525; GO:0050829; GO:0051092; GO:0055037; GO:0060349; GO:0061844; GO:0070062; GO:0071902; GO:0097013; GO:0140912; GO:1900159; GO:1900229; GO:1902732; GO:1904724; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; bone morphogenesis [GO:0060349]; defense response to Gram-negative bacterium [GO:0050829]; humoral immune response [GO:0006959]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; killing of cells of another organism [GO:0031640]; negative regulation by host of viral process [GO:0044793]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ATP-dependent activity [GO:0032780]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; negative regulation of viral genome replication [GO:0045071]; negative regulation of viral process [GO:0048525]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; phagocytic vesicle lumen [GO:0097013]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; secretory granule [GO:0030141]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cysteine-type endopeptidase inhibitor activity [GO:0004869]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; iron ion binding [GO:0005506]; lipopolysaccharide binding [GO:0001530]; membrane destabilizing activity [GO:0140912]; protein serine/threonine kinase activator activity [GO:0043539]; serine-type endopeptidase activity [GO:0004252],GO:0002376; GO:0003677; GO:0003824; GO:0005576; GO:0005615; GO:0005634; GO:0005768; GO:0005886; GO:0006355; GO:0008289; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0098772; GO:0140096,"immune system process; DNA binding; catalytic activity; extracellular region; extracellular space; nucleus; endosome; plasma membrane; regulation of DNA-templated transcription; lipid binding; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04609,0.3674439203697127,FUN_022305-T1,Peve_00003816,Pocillopora_meandrina_HIv1___RNAseq.g3971.t1,three_way,36.00233333333333,,,,,,,,,,,,,,,,,
OG_01483,0.3530849444963912,FUN_006117-T1,Peve_00011322,Pocillopora_meandrina_HIv1___RNAseq.g20401.t1,three_way,36.36283333333333,,,,,,,,,,,,,,,,,
OG_03671,0.3493586582421543,FUN_014916-T1,Peve_00003523,Pocillopora_meandrina_HIv1___RNAseq.g21079.t1,three_way,45.37166666666666,FUN_014916-T1,P00919,,,,,41.5,253.0,1.2e-44,183.0,sp|P00919|CAH2_RABIT Carbonic anhydrase 2 OS=Oryctolagus cuniculus OX=9986 GN=CA2 PE=1 SV=3,,,,,,
OG_09894,0.3482649879759892,FUN_042988-T1,Peve_00036062,Pocillopora_meandrina_HIv1___RNAseq.g7093.t1,three_way,53.70933333333333,,,,,,,,,,,,,,,,,
OG_07200,0.3478191032817506,FUN_032709-T2,Peve_00029921,Pocillopora_meandrina_HIv1___RNAseq.g29873.t1,three_way,77.85433333333333,FUN_032709-T2,F1QB54,PABPA_DANRE,,Polyadenylate-binding protein 1A (PABP-1A) (Poly(A)-binding protein 1A),Danio rerio (Zebrafish) (Brachydanio rerio),58.9,628.0,1.0999999999999999e-187,657.9,sp|F1QB54|PABPA_DANRE Polyadenylate-binding protein 1A OS=Danio rerio OX=7955 GN=pabpc1a PE=1 SV=1,GO:0003730; GO:0005634; GO:0005829; GO:0006397; GO:0006412; GO:0006417; GO:0007507; GO:0008143; GO:0008266; GO:0010494; GO:1990904,heart development [GO:0007507]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417]; translation [GO:0006412],cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266],GO:0003723; GO:0005634; GO:0005829; GO:0016071; GO:0043226; GO:0048856,RNA binding; nucleus; cytosol; mRNA metabolic process; organelle; anatomical structure development
OG_00258,0.3459102888465308,FUN_001025-T1,Peve_00041055,Pocillopora_meandrina_HIv1___RNAseq.g16888.t1,three_way,40.96733333333333,,,,,,,,,,,,,,,,,
OG_09178,0.344556773326327,FUN_039858-T1,Peve_00020641,Pocillopora_meandrina_HIv1___RNAseq.g7287.t1a,three_way,34.05316666666667,,,,,,,,,,,,,,,,,
OG_01955,0.3383249130787537,FUN_008021-T1,Peve_00031303,Pocillopora_meandrina_HIv1___RNAseq.g30342.t1,three_way,69.569,,,,,,,,,,,,,,,,,
OG_07103,0.3330570248866116,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_06086,0.3268057664156796,FUN_027084-T1,Peve_00013218,Pocillopora_meandrina_HIv1___RNAseq.g2808.t1,three_way,82.44433333333333,FUN_027084-T1,Q3ZBR6,,,,,77.6,49.0,1.5e-13,77.0,sp|Q3ZBR6|SEM1_BOVIN 26S proteasome complex subunit SEM1 OS=Bos taurus OX=9913 GN=SEM1 PE=3 SV=1,,,,,,
OG_03269,0.3255768811137553,FUN_013138-T1,Peve_00042391,Pocillopora_meandrina_HIv1___TS.g15900.t1,three_way,81.306,FUN_013138-T1,Q7RTY7,OVCH1_HUMAN,,Ovochymase-1 (EC 3.4.21.-),Homo sapiens (Human),39.4,251.0,5.999999999999999e-44,179.5,sp|Q7RTY7|OVCH1_HUMAN Ovochymase-1 OS=Homo sapiens OX=9606 GN=OVCH1 PE=1 SV=3,GO:0004252; GO:0005576; GO:0006508; GO:0046872,proteolysis [GO:0006508],extracellular region [GO:0005576],metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0016787; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; catalytic activity, acting on a protein"
OG_01095,0.3235205531643041,FUN_004591-T2,Peve_00012404,Pocillopora_meandrina_HIv1___RNAseq.g6591.t1,three_way,63.417,,,,,,,,,,,,,,,,,
OG_05611,0.3220822588003003,FUN_025296-T1,Peve_00001926,Pocillopora_meandrina_HIv1___RNAseq.g11490.t1,three_way,45.81016666666667,,,,,,,,,,,,,,,,,
OG_01995,0.3140644108619957,FUN_008104-T1,Peve_00019588,Pocillopora_meandrina_HIv1___RNAseq.g17898.t1,three_way,90.90516666666667,FUN_008104-T1,O57521,HS90B_DANRE,,Heat shock protein HSP 90-beta,Danio rerio (Zebrafish) (Brachydanio rerio),82.0,727.0,2.3e-304,1045.8,sp|O57521|HS90B_DANRE Heat shock protein HSP 90-beta OS=Danio rerio OX=7955 GN=hsp90ab1 PE=1 SV=2,GO:0001568; GO:0005524; GO:0005576; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0006457; GO:0007517; GO:0016887; GO:0030511; GO:0032435; GO:0032991; GO:0034605; GO:0034751; GO:0043627; GO:0046983; GO:0048471; GO:0050821; GO:0050900; GO:0051082; GO:0051726; GO:0120293; GO:0140662; GO:0141069,blood vessel development [GO:0001568]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; response to estrogen [GO:0043627],aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynein axonemal particle [GO:0120293]; extracellular region [GO:0005576]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; protein dimerization activity [GO:0046983]; receptor ligand inhibitor activity [GO:0141069]; unfolded protein binding [GO:0051082],GO:0002376; GO:0003824; GO:0005576; GO:0005634; GO:0005829; GO:0005886; GO:0006457; GO:0016787; GO:0043226; GO:0044183; GO:0048856; GO:0048870; GO:0098772; GO:0140657,immune system process; catalytic activity; extracellular region; nucleus; cytosol; plasma membrane; protein folding; hydrolase activity; organelle; protein folding chaperone; anatomical structure development; cell motility; molecular function regulator activity; ATP-dependent activity
OG_09963,0.3111654124227467,FUN_043144-T1,Peve_00034957,Pocillopora_meandrina_HIv1___RNAseq.g6886.t1,three_way,84.25150000000001,FUN_043144-T1,Q26481,,,,,73.1,279.0,2e-116,420.2,sp|Q26481|RL5_STYCL Large ribosomal subunit protein uL18 OS=Styela clava OX=7725 GN=RPL5 PE=3 SV=3,,,,,,
OG_08361,0.3097419439002352,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_04230,0.3090575896882206,FUN_017693-T1,Peve_00030752,Pocillopora_meandrina_HIv1___RNAseq.g23495.t1,three_way,47.43216666666667,,,,,,,,,,,,,,,,,
OG_02560,0.3057869065253069,FUN_010659-T1,Peve_00031472,Pocillopora_meandrina_HIv1___RNAseq.g21313.t1,three_way,90.361,FUN_010659-T1,Q76I81,,,,,81.8,121.0,1.5999999999999996e-53,209.9,sp|Q76I81|RS12_BOVIN Small ribosomal subunit protein eS12 OS=Bos taurus OX=9913 GN=RPS12 PE=2 SV=1,,,,,,
OG_07414,0.2948336159954028,FUN_033872-T1,Peve_00043319,Pocillopora_meandrina_HIv1___RNAseq.g28409.t1,three_way,53.156,,,,,,,,,,,,,,,,,
OG_08647,0.2943530654314379,FUN_037838-T1,Peve_00000575,Pocillopora_meandrina_HIv1___TS.g22869.t1,three_way,95.46833333333332,FUN_037838-T1,P62265,,,,,88.2,152.0,1.3e-68,260.4,sp|P62265|RS14_CRIGR Small ribosomal subunit protein uS11 OS=Cricetulus griseus OX=10029 GN=RPS14 PE=2 SV=3,,,,,,
OG_02101,0.2925095653820853,FUN_008377-T1,Peve_00024686,Pocillopora_meandrina_HIv1___RNAseq.g18396.t1,three_way,53.3375,,,,,,,,,,,,,,,,,
OG_08849,0.2901953106037934,FUN_038210-T1,Peve_00038842,Pocillopora_meandrina_HIv1___TS.g5429.t1,three_way,51.66433333333333,FUN_038210-T1,Q7TN88,,,,,27.8,967.0,4.1e-93,344.7,sp|Q7TN88|PK1L2_MOUSE Polycystin-1-like protein 2 OS=Mus musculus OX=10090 GN=Pkd1l2 PE=2 SV=1,,,,,,
OG_06799,0.2879984803717053,FUN_031687-T1,Peve_00021456,Pocillopora_meandrina_HIv1___RNAseq.g5769.t1,three_way,58.85433333333334,FUN_031687-T1,A1L1W9,MOT10_DANRE,,Monocarboxylate transporter 10 (MCT 10) (Solute carrier family 16 member 10),Danio rerio (Zebrafish) (Brachydanio rerio),28.0,440.0,4.8e-42,173.7,sp|A1L1W9|MOT10_DANRE Monocarboxylate transporter 10 OS=Danio rerio OX=7955 GN=slc16a10 PE=2 SV=1,GO:0005302; GO:0005886; GO:0015173; GO:0015192; GO:0015196; GO:0015349; GO:0015801; GO:0016323; GO:0022857; GO:0070327,aromatic amino acid transport [GO:0015801]; thyroid hormone transport [GO:0070327],basolateral plasma membrane [GO:0016323]; plasma membrane [GO:0005886],aromatic amino acid transmembrane transporter activity [GO:0015173]; L-phenylalanine transmembrane transporter activity [GO:0015192]; L-tryptophan transmembrane transporter activity [GO:0015196]; L-tyrosine transmembrane transporter activity [GO:0005302]; thyroid hormone transmembrane transporter activity [GO:0015349]; transmembrane transporter activity [GO:0022857],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_00511,0.2871986291899797,FUN_001503-T1,Peve_00018430,Pocillopora_meandrina_HIv1___RNAseq.g1086.t1,three_way,61.830666666666666,FUN_001503-T1,P86982,,,,,41.6,137.0,3.9e-21,103.6,sp|P86982|IMSP1_RUDPH Insoluble matrix shell protein 1 (Fragment) OS=Ruditapes philippinarum OX=129788 PE=1 SV=1,,,,,,
OG_00246,0.2864877658468508,FUN_001009-T1,Peve_00041033,Pocillopora_meandrina_HIv1___TS.g6384.t1,three_way,55.748666666666665,FUN_001009-T1,P97739,,,,,36.8,749.0,9.2e-134,479.2,sp|P97739|ECE1_CAVPO Endothelin-converting enzyme 1 OS=Cavia porcellus OX=10141 GN=ECE1 PE=2 SV=1,,,,,,
OG_07229,0.2857845563404367,FUN_032885-T1,Peve_00001722,Pocillopora_meandrina_HIv1___RNAseq.g29858.t1,three_way,52.5095,,,,,,,,,,,,,,,,,
OG_06234,0.2857796264118647,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_02090,0.285352620772373,FUN_008328-T1,Peve_00040489,Pocillopora_meandrina_HIv1___TS.g24166.t1,three_way,48.269666666666666,FUN_008328-T1,B3EWY9,,,,,39.3,990.0,2.1999999999999998e-166,589.3,sp|B3EWY9|MLP_ACRMI Mucin-like protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_09443,0.2847727307367011,FUN_041432-T2,Peve_00027845,Pocillopora_meandrina_HIv1___RNAseq.g15740.t1,three_way,86.71633333333334,FUN_041432-T2,Q90837,,,,,41.4,459.0,1.8000000000000002e-81,304.7,sp|Q90837|ERG_CHICK Transcriptional regulator Erg OS=Gallus gallus OX=9031 GN=ERG PE=2 SV=1,,,,,,
OG_02484,0.2827190678705187,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_01505,0.2815400283975152,FUN_006237-T1,Peve_00030695,Pocillopora_meandrina_HIv1___RNAseq.g20447.t1,three_way,90.30166666666666,FUN_006237-T1,Q9GP16,,,,,72.4,123.0,3.5e-48,192.2,sp|Q9GP16|RL31_HELVI Large ribosomal subunit protein eL31 OS=Heliothis virescens OX=7102 GN=RpL31 PE=2 SV=1,,,,,,
OG_07836,0.2791463888986148,FUN_035166-T1,Peve_00036194,Pocillopora_meandrina_HIv1___RNAseq.g27915.t1,three_way,52.95516666666667,FUN_035166-T1,Q29477,TRFL_CAPHI,,Lactotransferrin (Lactoferrin) (EC 3.4.21.-),Capra hircus (Goat),35.5,366.0,2.5e-42,174.5,sp|Q29477|TRFL_CAPHI Lactotransferrin OS=Capra hircus OX=9925 GN=LTF PE=1 SV=1,GO:0001503; GO:0001817; GO:0002227; GO:0005615; GO:0005769; GO:0005886; GO:0006508; GO:0006826; GO:0008236; GO:0019731; GO:0019732; GO:0031665; GO:0032680; GO:0033690; GO:0042581; GO:0043066; GO:0045669; GO:0046872; GO:0055037; GO:0060349; GO:1900159; GO:1900229; GO:1902732; GO:2000308; GO:2001205,antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; bone morphogenesis [GO:0060349]; innate immune response in mucosa [GO:0002227]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; negative regulation of osteoclast development [GO:2001205]; negative regulation of single-species biofilm formation in or on host organism [GO:1900229]; negative regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000308]; ossification [GO:0001503]; positive regulation of bone mineralization involved in bone maturation [GO:1900159]; positive regulation of chondrocyte proliferation [GO:1902732]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; proteolysis [GO:0006508]; regulation of cytokine production [GO:0001817]; regulation of tumor necrosis factor production [GO:0032680],early endosome [GO:0005769]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; specific granule [GO:0042581],metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236],GO:0002376; GO:0003824; GO:0005615; GO:0005768; GO:0005886; GO:0016787; GO:0031410; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; extracellular space; endosome; plasma membrane; hydrolase activity; cytoplasmic vesicle; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_00356,0.279112366954095,FUN_001188-T1,Peve_00009673,Pocillopora_meandrina_HIv1___TS.g6724.t2,three_way,43.03966666666667,,,,,,,,,,,,,,,,,
OG_05644,0.2779531191611462,FUN_025362-T1,Peve_00040527,Pocillopora_meandrina_HIv1___RNAseq.g13347.t1,three_way,93.85966666666668,FUN_025362-T1,Q5PQN7,,,,,68.9,190.0,6.3e-62,238.8,sp|Q5PQN7|LZIC_RAT Protein LZIC OS=Rattus norvegicus OX=10116 GN=Lzic PE=2 SV=1,,,,,,
OG_00304,0.2773030901882622,FUN_001106-T1,Peve_00003165,Pocillopora_meandrina_HIv1___RNAseq.g29367.t1b,three_way,75.54033333333334,,,,,,,,,,,,,,,,,
OG_03099,0.276480598959,FUN_012386-T1,Peve_00030648,Pocillopora_meandrina_HIv1___RNAseq.g23347.t1,three_way,52.83716666666666,,,,,,,,,,,,,,,,,
OG_09440,0.275983522718412,FUN_041426-T1,Peve_00008987,Pocillopora_meandrina_HIv1___RNAseq.g15735.t2,three_way,80.48633333333333,FUN_041426-T1,P97360,ETV6_MOUSE,,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),Mus musculus (Mouse),44.6,65.0,1.7e-11,70.9,sp|P97360|ETV6_MOUSE Transcription factor ETV6 OS=Mus musculus OX=10090 GN=Etv6 PE=1 SV=1,GO:0000978; GO:0001227; GO:0001228; GO:0003677; GO:0003700; GO:0005730; GO:0005829; GO:0006355; GO:0007296; GO:0019904; GO:0022008; GO:0030154; GO:0045944; GO:0071425; GO:0097152,cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; mesenchymal cell apoptotic process [GO:0097152]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; vitellogenesis [GO:0007296],cytosol [GO:0005829]; nucleolus [GO:0005730],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005730; GO:0005829; GO:0006355; GO:0012501; GO:0030154; GO:0043226; GO:0140110,DNA binding; nucleolus; cytosol; regulation of DNA-templated transcription; programmed cell death; cell differentiation; organelle; transcription regulator activity
OG_03116,0.2737435003419437,FUN_012430-T1,Peve_00026925,Pocillopora_meandrina_HIv1___RNAseq.g23681.t1,three_way,55.942,FUN_012430-T1,Q7TXL8,,,,,25.4,2226.0,7.9e-140,501.5,sp|Q7TXL8|PPSC_MYCBO Phenolphthiocerol/phthiocerol polyketide synthase subunit C OS=Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) OX=233413 GN=ppsC PE=1 SV=1,,,,,,
OG_05395,0.2726427687903999,FUN_024222-T1,Peve_00031895,Pocillopora_meandrina_HIv1___RNAseq.g18914.t1,three_way,77.07900000000001,FUN_024222-T1,Q13887,KLF5_HUMAN,,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),Homo sapiens (Human),38.6,166.0,5.3e-19,96.7,sp|Q13887|KLF5_HUMAN Krueppel-like factor 5 OS=Homo sapiens OX=9606 GN=KLF5 PE=1 SV=2,GO:0000122; GO:0000785; GO:0000978; GO:0000981; GO:0001228; GO:0001525; GO:0005654; GO:0005667; GO:0005794; GO:0006357; GO:0008270; GO:0008284; GO:0014816; GO:0014901; GO:0014908; GO:0030033; GO:0032534; GO:0043231; GO:0043426; GO:0045600; GO:0045944; GO:0060576; GO:0061586; GO:1901653; GO:1990830; GO:1990837,angiogenesis [GO:0001525]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to peptide [GO:1901653]; intestinal epithelial cell development [GO:0060576]; microvillus assembly [GO:0030033]; myotube differentiation involved in skeletal muscle regeneration [GO:0014908]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by transcription factor localization [GO:0061586]; regulation of microvillus assembly [GO:0032534]; regulation of transcription by RNA polymerase II [GO:0006357]; satellite cell activation involved in skeletal muscle regeneration [GO:0014901]; skeletal muscle satellite cell differentiation [GO:0014816],chromatin [GO:0000785]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; transcription regulator complex [GO:0005667],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; MRF binding [GO:0043426]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005654; GO:0005794; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleoplasm; Golgi apparatus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_04538,0.2723253155680909,FUN_022094-T1,Peve_00038682,Pocillopora_meandrina_HIv1___RNAseq.g4121.t1,three_way,74.00383333333333,FUN_022094-T1,Q5R5C1,UROM_PONAB,,"Uromodulin [Cleaved into: Uromodulin, secreted form]",Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),25.9,336.0,2.6e-20,101.7,sp|Q5R5C1|UROM_PONAB Uromodulin OS=Pongo abelii OX=9601 GN=UMOD PE=2 SV=1,GO:0000922; GO:0005509; GO:0005576; GO:0005929; GO:0016020; GO:0016323; GO:0016324; GO:0050829; GO:0060170; GO:0098552; GO:0140367,antibacterial innate immune response [GO:0140367]; defense response to Gram-negative bacterium [GO:0050829],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; extracellular region [GO:0005576]; membrane [GO:0016020]; side of membrane [GO:0098552]; spindle pole [GO:0000922],calcium ion binding [GO:0005509],GO:0002376; GO:0005576; GO:0005929; GO:0043226; GO:0098542,immune system process; extracellular region; cilium; organelle; defense response to other organism
OG_06360,0.2718626020446129,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_02929,0.2718285329308599,FUN_012028-T1,Peve_00030379,Pocillopora_meandrina_HIv1___RNAseq.g24047.t2,three_way,77.09433333333334,FUN_012028-T1,Q14192,FHL2_HUMAN,,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),Homo sapiens (Human),42.1,273.0,1.7000000000000002e-74,282.0,sp|Q14192|FHL2_HUMAN Four and a half LIM domains protein 2 OS=Homo sapiens OX=9606 GN=FHL2 PE=1 SV=3,GO:0000122; GO:0001649; GO:0003714; GO:0005634; GO:0005654; GO:0005925; GO:0008134; GO:0008270; GO:0009725; GO:0030018; GO:0042802; GO:0043066; GO:0043425; GO:0055014; GO:0055015; GO:0060347; GO:0070885,atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Z disc [GO:0030018],bHLH transcription factor binding [GO:0043425]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0060090; GO:0140110,nucleus; nucleoplasm; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; molecular adaptor activity; transcription regulator activity
OG_05654,0.270591918193134,FUN_025403-T1,Peve_00026689,Pocillopora_meandrina_HIv1___RNAseq.g13308.t1,three_way,71.69633333333334,FUN_025403-T1,Q7SXN5,DNM1L_DANRE,,Dynamin-1-like protein (EC 3.6.5.5),Danio rerio (Zebrafish) (Brachydanio rerio),21.1,701.0,1.2e-07,60.1,sp|Q7SXN5|DNM1L_DANRE Dynamin-1-like protein OS=Danio rerio OX=7955 GN=dnm1l PE=2 SV=1,GO:0000266; GO:0003924; GO:0005525; GO:0005737; GO:0005739; GO:0005741; GO:0005777; GO:0005794; GO:0005829; GO:0005874; GO:0005905; GO:0006897; GO:0008017; GO:0008289; GO:0016020; GO:0016559; GO:0030672; GO:0042803; GO:0043653; GO:0048312; GO:0048511; GO:0051259,endocytosis [GO:0006897]; intracellular distribution of mitochondria [GO:0048312]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; rhythmic process [GO:0048511],clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0003924; GO:0005739; GO:0005777; GO:0005794; GO:0005829; GO:0007005; GO:0008092; GO:0008289; GO:0016192; GO:0016787; GO:0043226; GO:0065003,catalytic activity; GTPase activity; mitochondrion; peroxisome; Golgi apparatus; cytosol; mitochondrion organization; cytoskeletal protein binding; lipid binding; vesicle-mediated transport; hydrolase activity; organelle; protein-containing complex assembly
OG_06491,0.2705774982459076,FUN_029269-T1,Peve_00002504,Pocillopora_meandrina_HIv1___RNAseq.g25417.t1,three_way,91.27916666666668,FUN_029269-T1,P08110,,,,,69.4,779.0,1.7e-282,973.4,sp|P08110|ENPL_CHICK Endoplasmin OS=Gallus gallus OX=9031 GN=HSP90B1 PE=1 SV=1,,,,,,
OG_09472,0.2701531046630789,FUN_041498-T1,Peve_00007700,Pocillopora_meandrina_HIv1___TS.g10682.t1,three_way,80.48866666666666,FUN_041498-T1,Q6Q2B2,,,,,39.5,253.0,1.1e-33,145.6,sp|Q6Q2B2|MBN2A_TAKRU Muscleblind-like protein 2a OS=Takifugu rubripes OX=31033 GN=mbnl2a PE=2 SV=1,,,,,,
OG_02311,0.2689810615077422,FUN_008898-T1,Peve_00041461,Pocillopora_meandrina_HIv1___RNAseq.g3963.t1,three_way,52.316500000000005,FUN_008898-T1,Q2EMV9,PAR14_MOUSE,,Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (Collaborator of STAT6) (CoaSt6) (Poly [ADP-ribose] polymerase 14) (PARP-14),Mus musculus (Mouse),31.0,775.0,1.8e-87,326.6,sp|Q2EMV9|PAR14_MOUSE Protein mono-ADP-ribosyltransferase PARP14 OS=Mus musculus OX=10090 GN=Parp14 PE=1 SV=3,GO:0003950; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0010629; GO:0016779; GO:0019899; GO:0045087; GO:0060336; GO:0140807; GO:1902216; GO:1990404,innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],enzyme binding [GO:0019899]; NAD+ poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein mono-ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; nucleotidyltransferase activity [GO:0016779],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0005886; GO:0016740; GO:0043226; GO:0098542; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; plasma membrane; transferase activity; organelle; defense response to other organism; catalytic activity, acting on a protein"
OG_04559,0.2687522782859866,FUN_022198-T1,Peve_00038010,Pocillopora_meandrina_HIv1___RNAseq.g4797.t1,three_way,68.02633333333333,,,,,,,,,,,,,,,,,
OG_05809,0.2685920909340737,FUN_025809-T2,Peve_00017944,Pocillopora_meandrina_HIv1___TS.g19642.t2,three_way,56.2395,FUN_025809-T2,Q08EN7,,,,,29.7,286.0,1.6e-26,122.5,sp|Q08EN7|ZCPW2_MOUSE Zinc finger CW-type PWWP domain protein 2 homolog OS=Mus musculus OX=10090 GN=Zcwpw2 PE=2 SV=2,,,,,,
OG_07835,0.2667025503002783,FUN_035161-T1,Peve_00006324,Pocillopora_meandrina_HIv1___RNAseq.11026_t,three_way,61.05166666666667,FUN_035161-T1,Q923Y6,,,,,26.7,330.0,9.8e-13,75.9,sp|Q923Y6|TAAR9_RAT Trace amine-associated receptor 9 OS=Rattus norvegicus OX=10116 GN=Taar9 PE=2 SV=1,,,,,,
OG_04508,0.2666303669604006,FUN_022036-T1,Peve_00019003,Pocillopora_meandrina_HIv1___RNAseq.g9285.t1,three_way,61.077333333333335,,,,,,,,,,,,,,,,,
OG_09233,0.2662671764451959,FUN_039977-T1,Peve_00029897,Pocillopora_meandrina_HIv1___RNAseq.g7542.t1,three_way,56.55166666666666,FUN_039977-T1,Q9ULJ7,,,,,25.1,427.0,1.1e-26,124.8,sp|Q9ULJ7|ANR50_HUMAN Ankyrin repeat domain-containing protein 50 OS=Homo sapiens OX=9606 GN=ANKRD50 PE=1 SV=4,,,,,,
OG_05136,0.2648695378450242,FUN_023407-T1,Peve_00016102,Pocillopora_meandrina_HIv1___RNAseq.g17552.t1,three_way,89.46416666666667,FUN_023407-T1,P24032,,,,,63.5,170.0,1.6e-54,213.8,"sp|P24032|MLRN_CHICK Myosin regulatory light chain 2, smooth muscle minor isoform OS=Gallus gallus OX=9031 PE=1 SV=2",,,,,,
OG_08844,0.2628351636617809,FUN_038195-T1,Peve_00008324,Pocillopora_meandrina_HIv1___RNAseq.g939.t1,three_way,54.577666666666666,,,,,,,,,,,,,,,,,
OG_05192,0.2623955629601938,FUN_023558-T1,Peve_00037258,Pocillopora_meandrina_HIv1___RNAseq.g519.t1,three_way,71.653,FUN_023558-T1,P29419,,,,,46.3,67.0,8.1e-07,53.9,"sp|P29419|ATP5I_RAT ATP synthase F(0) complex subunit e, mitochondrial OS=Rattus norvegicus OX=10116 GN=Atp5me PE=1 SV=3",,,,,,
OG_06373,0.2613081892577748,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_05826,0.2612182689004265,FUN_025843-T1,Peve_00028316,Pocillopora_meandrina_HIv1___RNAseq.g10339.t1,three_way,66.52566666666667,,,,,,,,,,,,,,,,,
OG_05637,0.2603198416004308,FUN_025338-T2,Peve_00000776,Pocillopora_meandrina_HIv1___RNAseq.g24106.t1,three_way,62.506,,,,,,,,,,,,,,,,,
OG_06674,0.2573077672018586,FUN_031077-T3,Peve_00028144,Pocillopora_meandrina_HIv1___RNAseq.g30317.t1,three_way,76.78383333333333,FUN_031077-T3,Q3V2A7,QRIC2_MOUSE,,Glutamine-rich protein 2,Mus musculus (Mouse),31.8,337.0,1.4e-27,126.7,sp|Q3V2A7|QRIC2_MOUSE Glutamine-rich protein 2 OS=Mus musculus OX=10090 GN=Qrich2 PE=2 SV=1,GO:0005634; GO:0005737; GO:0030031; GO:0030317; GO:0031965; GO:0036126; GO:2000059,cell projection assembly [GO:0030031]; flagellated sperm motility [GO:0030317]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059],cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; sperm flagellum [GO:0036126],,GO:0005634; GO:0005929; GO:0007018; GO:0022414; GO:0043226; GO:0048870,nucleus; cilium; microtubule-based movement; reproductive process; organelle; cell motility
OG_07731,0.2569460356652493,FUN_034892-T1,Peve_00037338,Pocillopora_meandrina_HIv1___TS.g15150.t1,three_way,61.52,,,,,,,,,,,,,,,,,
OG_00242,0.2564667091568529,FUN_001005-T1,Peve_00015285,Pocillopora_meandrina_HIv1___TS.g6390.t1,three_way,40.208,,,,,,,,,,,,,,,,,
OG_02532,0.2562612801767597,FUN_010610-T1,Peve_00002553,Pocillopora_meandrina_HIv1___RNAseq.g9919.t1,three_way,68.22433333333333,,,,,,,,,,,,,,,,,
OG_01463,0.2559992366245123,FUN_005998-T1,Peve_00036045,Pocillopora_meandrina_HIv1___RNAseq.g19934.t1,three_way,70.90683333333334,FUN_005998-T1,P23780,BGAL_MOUSE,,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase),Mus musculus (Mouse),50.4,625.0,1.3e-181,637.9,sp|P23780|BGAL_MOUSE Beta-galactosidase OS=Mus musculus OX=10090 GN=Glb1 PE=1 SV=1,GO:0004565; GO:0005615; GO:0005737; GO:0005764; GO:0005794; GO:0006516; GO:0006689; GO:0016020; GO:0016787; GO:0016936; GO:0019388; GO:0042340; GO:0042803; GO:0051413; GO:1904016,galactose catabolic process [GO:0019388]; ganglioside catabolic process [GO:0006689]; glycoprotein catabolic process [GO:0006516]; keratan sulfate proteoglycan catabolic process [GO:0042340]; response to cortisone [GO:0051413]; response to Thyroglobulin triiodothyronine [GO:1904016],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020],beta-galactosidase activity [GO:0004565]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803],GO:0003824; GO:0005615; GO:0005764; GO:0005773; GO:0005794; GO:0005975; GO:0006629; GO:0016787; GO:0030163; GO:0043226; GO:1901135,catalytic activity; extracellular space; lysosome; vacuole; Golgi apparatus; carbohydrate metabolic process; lipid metabolic process; hydrolase activity; protein catabolic process; organelle; carbohydrate derivative metabolic process
OG_06627,0.2550425622754153,FUN_030057-T1,Peve_00027775,Pocillopora_meandrina_HIv1___RNAseq.g17349.t1,three_way,71.34366666666666,FUN_030057-T1,Q19425,,,,,43.3,536.0,1.2e-109,398.7,sp|Q19425|S38A9_CAEEL Sodium-coupled neutral amino acid transporter 9 homolog OS=Caenorhabditis elegans OX=6239 GN=F13H10.3 PE=3 SV=2,,,,,,
OG_08697,0.2544215258382299,FUN_037943-T2,Peve_00027812,Pocillopora_meandrina_HIv1___RNAseq.g26522.t1,three_way,43.655,,,,,,,,,,,,,,,,,
OG_03941,0.2542221305473377,FUN_016076-T1,Peve_00021921,Pocillopora_meandrina_HIv1___RNAseq.g21616.t1,three_way,70.497,FUN_016076-T1,Q9C9C6,,,,,49.4,180.0,1.2e-34,147.9,sp|Q9C9C6|RL62_ARATH Large ribosomal subunit protein eL6y OS=Arabidopsis thaliana OX=3702 GN=RPL6B PE=2 SV=1,,,,,,
OG_09798,0.2537504333403841,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_05477,0.2536617839051935,FUN_024467-T1,Peve_00026395,Pocillopora_meandrina_HIv1___RNAseq.g18560.t1,three_way,49.363166666666665,,,,,,,,,,,,,,,,,
OG_07360,0.2534451527527556,FUN_033771-T1,Peve_00006491,Pocillopora_meandrina_HIv1___RNAseq.g26660.t1,three_way,47.66133333333333,FUN_033771-T1,Q7JQD3,GELS1_LUMTE,,Gelsolin-like protein 1 (Actin-modulator) (EWAM) (EWAM-P1),Lumbricus terrestris (Common earthworm),34.7,340.0,7.799999999999999e-49,196.1,sp|Q7JQD3|GELS1_LUMTE Gelsolin-like protein 1 OS=Lumbricus terrestris OX=6398 GN=AM PE=1 SV=1,GO:0003779; GO:0005509; GO:0005737; GO:0015629; GO:0030041; GO:0030043; GO:0045010; GO:0051014; GO:0051015; GO:0051693,actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737],actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509],GO:0005856; GO:0008092; GO:0043226; GO:0065003,cytoskeleton; cytoskeletal protein binding; organelle; protein-containing complex assembly
OG_05813,0.2524638815027096,FUN_025815-T1,Peve_00002524,Pocillopora_meandrina_HIv1___RNAseq.g9337.t1,three_way,46.56366666666667,FUN_025815-T1,O35565,FGF10_MOUSE,,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),Mus musculus (Mouse),32.5,126.0,2e-11,71.2,sp|O35565|FGF10_MOUSE Fibroblast growth factor 10 OS=Mus musculus OX=10090 GN=Fgf10 PE=2 SV=1,GO:0000132; GO:0000278; GO:0001525; GO:0001759; GO:0001823; GO:0001935; GO:0001938; GO:0001974; GO:0003338; GO:0005111; GO:0005615; GO:0005634; GO:0005886; GO:0006935; GO:0007267; GO:0007368; GO:0007435; GO:0008083; GO:0008201; GO:0008283; GO:0008544; GO:0008589; GO:0009880; GO:0009887; GO:0009986; GO:0010468; GO:0010634; GO:0010838; GO:0016055; GO:0021983; GO:0030036; GO:0030177; GO:0030324; GO:0030538; GO:0030855; GO:0030857; GO:0030878; GO:0030916; GO:0030949; GO:0031016; GO:0031069; GO:0031076; GO:0032355; GO:0032496; GO:0032808; GO:0032925; GO:0034394; GO:0035019; GO:0035108; GO:0035265; GO:0042056; GO:0042060; GO:0042246; GO:0042472; GO:0042475; GO:0042693; GO:0043616; GO:0045739; GO:0045747; GO:0045893; GO:0045931; GO:0045944; GO:0046579; GO:0046877; GO:0048010; GO:0048144; GO:0048146; GO:0048286; GO:0048514; GO:0048536; GO:0048538; GO:0048557; GO:0048565; GO:0048566; GO:0048645; GO:0048730; GO:0048752; GO:0048807; GO:0048808; GO:0050671; GO:0050673; GO:0050674; GO:0050677; GO:0050679; GO:0050872; GO:0050918; GO:0050930; GO:0051145; GO:0051549; GO:0060019; GO:0060173; GO:0060174; GO:0060425; GO:0060428; GO:0060430; GO:0060436; GO:0060441; GO:0060445; GO:0060447; GO:0060449; GO:0060496; GO:0060510; GO:0060513; GO:0060541; GO:0060594; GO:0060595; GO:0060615; GO:0060661; GO:0060664; GO:0060665; GO:0060667; GO:0060879; GO:0060915; GO:0061033; GO:0061115; GO:0070075; GO:0070343; GO:0070352; GO:0070371; GO:0070374; GO:0070384; GO:0071338; GO:0072089; GO:0090263; GO:0097192; GO:1900087; GO:1902178; GO:2000647; GO:2000648; GO:2001240,actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ formation [GO:0048645]; animal organ morphogenesis [GO:0009887]; blood vessel morphogenesis [GO:0048514]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in salivary gland morphogenesis [GO:0060445]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell population proliferation [GO:0008283]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; endothelial cell proliferation [GO:0001935]; epidermis development [GO:0008544]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast proliferation [GO:0048144]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; inner ear morphogenesis [GO:0042472]; keratinocyte proliferation [GO:0043616]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mammary gland specification [GO:0060594]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros morphogenesis [GO:0003338]; mitotic cell cycle [GO:0000278]; muscle cell fate commitment [GO:0042693]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of stem cell proliferation [GO:2000647]; odontogenesis of dentin-containing tooth [GO:0042475]; organ growth [GO:0035265]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; positive regulation of Wnt signaling pathway [GO:0030177]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of gene expression [GO:0010468]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; respiratory system development [GO:0060541]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland morphogenesis [GO:0007435]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; semicircular canal morphogenesis [GO:0048752]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; stem cell proliferation [GO:0072089]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; white fat cell differentiation [GO:0050872]; white fat cell proliferation [GO:0070343]; Wnt signaling pathway [GO:0016055]; wound healing [GO:0042060],cell surface [GO:0009986]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886],chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111],GO:0000278; GO:0005615; GO:0005634; GO:0005886; GO:0006355; GO:0007010; GO:0022414; GO:0023052; GO:0030154; GO:0042060; GO:0043226; GO:0048018; GO:0048856; GO:0098772,mitotic cell cycle; extracellular space; nucleus; plasma membrane; regulation of DNA-templated transcription; cytoskeleton organization; reproductive process; signaling; cell differentiation; wound healing; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity
OG_05031,0.251502658320564,FUN_023205-T1,Peve_00010002,Pocillopora_meandrina_HIv1___RNAseq.g681.t2,three_way,61.8175,FUN_023205-T1,Q9H4G4,GAPR1_HUMAN,,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),Homo sapiens (Human),41.3,150.0,3.5e-26,119.8,sp|Q9H4G4|GAPR1_HUMAN Golgi-associated plant pathogenesis-related protein 1 OS=Homo sapiens OX=9606 GN=GLIPR2 PE=1 SV=3,GO:0000139; GO:0005615; GO:0010634; GO:0010718; GO:0019953; GO:0042803; GO:0070062; GO:0070374,positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; sexual reproduction [GO:0019953],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139],protein homodimerization activity [GO:0042803],GO:0005615; GO:0022414; GO:0043226,extracellular space; reproductive process; organelle
OG_01450,0.2501423808875185,FUN_005904-T1,Peve_00035815,Pocillopora_meandrina_HIv1___RNAseq.2460_t,three_way,73.63866666666667,FUN_005904-T1,P55115,,,,,42.3,239.0,1e-48,195.3,sp|P55115|NAS15_CAEEL Zinc metalloproteinase nas-15 OS=Caenorhabditis elegans OX=6239 GN=nas-15 PE=2 SV=2,,,,,,
OG_04999,0.2495715648494699,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_09091,0.2495209823540771,FUN_038889-T1,Peve_00028699,Pocillopora_meandrina_HIv1___RNAseq.g28663.t1,three_way,51.704,,,,,,,,,,,,,,,,,
OG_06366,0.2470082515958015,FUN_028970-T1,Peve_00006113,Pocillopora_meandrina_HIv1___RNAseq.g25636.t1,three_way,82.70400000000001,FUN_028970-T1,P13195,HEM1_RAT,,"5-aminolevulinate synthase, non-specific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",Rattus norvegicus (Rat),52.0,611.0,1.8e-169,597.4,"sp|P13195|HEM1_RAT 5-aminolevulinate synthase, non-specific, mitochondrial OS=Rattus norvegicus OX=10116 GN=Alas1 PE=2 SV=2",GO:0001666; GO:0003870; GO:0005654; GO:0005739; GO:0005743; GO:0005759; GO:0005829; GO:0006782; GO:0006783; GO:0006784; GO:0006785; GO:0009410; GO:0009635; GO:0010045; GO:0030170; GO:0031667; GO:0032025; GO:0032869; GO:0034698; GO:0042541; GO:0042802; GO:0045471; GO:0048034; GO:0048821; GO:0051591; GO:0070541; GO:1903412,cellular response to insulin stimulus [GO:0032869]; erythrocyte development [GO:0048821]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; hemoglobin biosynthetic process [GO:0042541]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to bile acid [GO:1903412]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to platinum ion [GO:0070541]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],5-aminolevulinate synthase activity [GO:0003870]; identical protein binding [GO:0042802]; pyridoxal phosphate binding [GO:0030170],GO:0003824; GO:0005654; GO:0005739; GO:0005829; GO:0016740; GO:0043226; GO:0048856,catalytic activity; nucleoplasm; mitochondrion; cytosol; transferase activity; organelle; anatomical structure development
OG_04096,0.2455985121289783,FUN_016436-T1,Peve_00002886,Pocillopora_meandrina_HIv1___TS.g23399.t2,three_way,66.57249999999999,FUN_016436-T1,P05455,LA_HUMAN,,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),46.4,196.0,2.2e-38,160.6,sp|P05455|LA_HUMAN Lupus La protein OS=Homo sapiens OX=9606 GN=SSB PE=1 SV=2,GO:0000049; GO:0000781; GO:0001682; GO:0003723; GO:0003729; GO:0005634; GO:0005737; GO:0005829; GO:0006400; GO:0006409; GO:0008033; GO:0008266; GO:0008334; GO:0010494; GO:0042780; GO:0045727; GO:0071045; GO:0075522; GO:1903608; GO:1990825; GO:1990904,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005829; GO:0006399; GO:0006913; GO:0016071; GO:0043226,RNA binding; nucleus; cytosol; tRNA metabolic process; nucleocytoplasmic transport; mRNA metabolic process; organelle
OG_01518,0.2446099034210973,FUN_006261-T1,Peve_00015046,Pocillopora_meandrina_HIv1___RNAseq.g20376.t1,three_way,47.83533333333333,,,,,,,,,,,,,,,,,
OG_03500,0.244259511203353,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_04801,0.2428465528798822,FUN_022758-T1,Peve_00027945,Pocillopora_meandrina_HIv1___RNAseq.g3153.t1,three_way,64.09166666666667,,,,,,,,,,,,,,,,,
OG_01472,0.2418470595754773,FUN_006009-T1,Peve_00032112,Pocillopora_meandrina_HIv1___RNAseq.g28362.t1,three_way,43.14983333333333,,,,,,,,,,,,,,,,,
OG_09783,0.241549707349516,FUN_042583-T1,Peve_00034294,Pocillopora_meandrina_HIv1___RNAseq.g16882.t1,three_way,83.662,FUN_042583-T1,P09132,SRP19_HUMAN,,Signal recognition particle 19 kDa protein (SRP19),Homo sapiens (Human),47.1,140.0,3.1000000000000002e-27,122.9,sp|P09132|SRP19_HUMAN Signal recognition particle 19 kDa protein OS=Homo sapiens OX=9606 GN=SRP19 PE=1 SV=3,GO:0003723; GO:0005730; GO:0005786; GO:0005829; GO:0006613; GO:0006617; GO:0008312; GO:0016604; GO:0048500,"cotranslational protein targeting to membrane [GO:0006613]; SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition [GO:0006617]","cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; signal recognition particle [GO:0048500]; signal recognition particle, endoplasmic reticulum targeting [GO:0005786]",7S RNA binding [GO:0008312]; RNA binding [GO:0003723],GO:0003723; GO:0005730; GO:0005829; GO:0043226; GO:0065003,RNA binding; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_09146,0.2414508021502831,FUN_039798-T1,Peve_00017577,Pocillopora_meandrina_HIv1___RNAseq.g7474.t1,three_way,69.27600000000001,,,,,,,,,,,,,,,,,
OG_03276,0.2396775432719779,FUN_013155-T1,Peve_00022447,Pocillopora_meandrina_HIv1___RNAseq.g12980.t1,three_way,66.7205,FUN_013155-T1,P47843,GTR3_SHEEP,,"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)",Ovis aries (Sheep),45.7,466.0,1.4000000000000001e-101,371.7,"sp|P47843|GTR3_SHEEP Solute carrier family 2, facilitated glucose transporter member 3 OS=Ovis aries OX=9940 GN=SLC2A3 PE=2 SV=1",GO:0005354; GO:0005536; GO:0005886; GO:0015757; GO:0016020; GO:0042995; GO:0043204; GO:0046323; GO:0055056; GO:0070837; GO:1904659,D-glucose import [GO:0046323]; D-glucose transmembrane transport [GO:1904659]; dehydroascorbic acid transport [GO:0070837]; galactose transmembrane transport [GO:0015757],cell projection [GO:0042995]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886],D-glucose binding [GO:0005536]; D-glucose transmembrane transporter activity [GO:0055056]; galactose transmembrane transporter activity [GO:0005354],GO:0005215; GO:0005886; GO:0055085,transporter activity; plasma membrane; transmembrane transport
